Skip to main navigation Skip to search Skip to main content

Diagnostic efficacy of tumor biomarkers AFP, CA19-9, and CEA in Hepatocellular carcinoma patients

  • Tufael
  • , Auditi Kar
  • , Md Haroon Or Rashid
  • , Atiqur Rahman Sunny
  • , António Raposo
  • , Md Saidul Islam
  • , Md Anower Hussain
  • , Mohammad Anowar Hussen
  • , Heesup Han
  • , Henrique Douglas Melo Coutinho
  • , Md Sefaut Ullah
  • , Md Mizanur Rahman
  • Parul University
  • Noakhali Science and Technology University
  • Kagoshima University
  • Pathfinder Research and Consultancy Center
  • Lusófona University
  • Korea Institute of Radiological and Medical Sciences
  • Bangladesh University of Health Sciences
  • University of Creative Technology Chittagong
  • Sejong University
  • Regional University of Cariri
  • Ibn Sina Trust

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)
100 Downloads (Pure)

Abstract

Background: Current diagnostic methods, including tumor markers such as alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA19-9), and carcinoembryonic antigen (CEA), have limitations in sensitivity and specificity, particularly in differentiating Hepatocellular carcinoma (HCC) from chronic liver diseases. This study investigated the diagnostic efficacy of these markers, individually and in combination, using chemiluminescence assay (CLIA) in patients with and without HCC. Methods: A cross-sectional study design was employed, analyzing data from 800 patients at Ibn Sina Diagnostic and Imaging Center in Dhaka. Tumor marker levels were assessed using CLIA kits, and associations with HCC diagnosis, tumor differentiation, occupation, age, and tumor size were examined. Results: Descriptive statistics revealed higher tumor marker levels in poorly differentiated tumors compared to welldifferentiated ones and controls. The combination of AFP, CA19-9, and CEA showed superior diagnostic accuracy for HCC, with a sensitivity of 86.5% and specificity of 92.3%. Occupation and age were found to correlate with tumor marker levels and HCC risk, with certain occupations and older age associated with larger tumor sizes. Regression analysis confirmed the associations between tumor markers and HCC. Conclusions: The study demonstrated the potential of AFP, CA19-9, and CEA as a panel of tumor markers for HCC detection and monitoring. CLIA emerged as a reliable diagnostic tool, offering high specificity and accuracy. Occupational factors and age were identified as relevant considerations in HCC risk assessment.
Original languageEnglish
Article number9513
Number of pages10
JournalJournal of Angiotherapy
Volume8
Issue number4
DOIs
Publication statusPublished - Apr 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chemiluminescence immunoassay
  • Early diagnosis
  • Hepatocellular carcinoma
  • Occupational exposure
  • Tumor markers

Fingerprint

Dive into the research topics of 'Diagnostic efficacy of tumor biomarkers AFP, CA19-9, and CEA in Hepatocellular carcinoma patients'. Together they form a unique fingerprint.

Cite this